Real-world experience with TTFields in glioma patients with emphasis on therapy usage
Tumor Treating Fields (TTFields) has emerged as a significant adjunctive component in the treatment of high-grade gliomas following the EF-14 trial in 2017. The incorporation of TTFields, alongside cyclic temozolomide therapy, has demonstrated improved patient outcomes when the usage exceeds 18 h pe...
Shranjeno v:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2025-01-01
|
| Serija: | Frontiers in Oncology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1430793/full |
| Oznake: |
Brez oznak, prvi označite!
|